Monobind Inc. Information

Monobind Inc. is a leader in diagnostic innovation and immunoassay development. Founded in 1978 and headquartered in California, the company has grown into one of the industry’s largest independent IVD manufacturers, with a portfolio of more than 160 assays across the AccuBind® ELISA and AccuLite® CLIA platforms. As a science-driven organization, Monobind develops solutions across multiple assay formats, including microplate, monotest, magnetic-bead technologies, lateral flow assays (LFA), and microarray platforms, supporting testing of serum, plasma, and whole blood samples. These solutions enable laboratories and point-of-care (POC) settings to implement scalable workflows ranging from manual reader-based testing to fully automated analyzers, including random-access platforms. In addition to finished diagnostic assays, Monobind supplies high-quality biomaterials and specialty reagents—including buffers and stabilizers—that support assay development and manufacturing throughout the global diagnostics industry. Operating under FDA registration and ISO 13485–certified quality systems, Monobind distributes CE-marked assays, diagnostic technologies, and biomaterials to partners and laboratories in more than 100 countries worldwide.